If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

As a neuropharmacologist I have contributed to the understanding of brain circuitry, particularly the involvement of the neurotransmitter dopamine on regulating brain function using rodent models. In the past few years I have discovered neurotransmitter/neurochemical interactions that regulate behaviours associated with drug abuse and dietary intake, such as: reward, addiction, psychoses, depression, anxiety and memory function. I am a member of the Centre for Emotional Health, Frontiers in Biomolecular Research Centre and the Centre for Nanoscale BioPhotonics (Australian Research Council Centre of Excellence).  

Research interests

I am particularly interested in understanding the neurobiology of:

  • drug (methamphetamine) addiction
  • drug (methamphetamine)-induced psychosis
  • alcopop addiction
  • anxiety
  • oxytocin as a therapeutic
  • cannabinoids as therapeutics
  • brain circuitry - dopamine, glutamate, GABA

Research student supervision

I supervise honours, Clinical Masters (Neuropsychology), Masters of Research and PhD candidates studying the impact of drug abuse on mental health for pharmacotherapeutic discovery.

Teaching

  • PSYC104 First year Psychology (Lecturer)
  • PSY236 Biopsychology & Learning (Lecturer, co-convenor)
  • PSY354 Clinical and Experimental Neuroscience (Convenor, Lecturer)
  • PSYN841/987 Clinical Psychopharmacology (Convenor, Lecturer)
  • MRES700 Research Communications (Convenor, Lecturer)
  • MEDI303 Neuroscience 2 (Guest Lecturer)

Research engagement

Research affiliations:

  • Centre for Emotional Health
  • Center for Atypical Neurodevelopment
  • Frontiers in Biomolecular Research Centre
  • Centre for Nanoscale BioPhotonics (ARC, AI)
  • Australasian Neuroscience Society
  • British Society of Neuroendocrinology
  • Kinoxis Pharmaceuticals
  • Lambert Initiative

Community engagement

  • Panel member for the National Health and Medical Research Council
  • Associate Dean, Higher Degree Research for the Faculty of Human Sciences
  • Frequent reviewer for neuroscience and pharmacology journals

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Methamphetamine Medicine & Life Sciences
N-Methyl-3,4-methylenedioxyamphetamine Medicine & Life Sciences
Self Administration Medicine & Life Sciences
Oxytocin Medicine & Life Sciences
Nucleus Accumbens Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Prefrontal Cortex Medicine & Life Sciences
Cocaine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2019

Research Output 1994 2018

A comparison of methamphetamine-induced psychosis and schizophrenia: a review of positive, negative, and cognitive symptomatology

Wearne, T. A. & Cornish, J. L., 10 Oct 2018, In : Frontiers in Psychiatry. 9, OCT, p. 1-21 21 p., 491.

Research output: Contribution to journalReview articleResearchpeer-review

Open Access
File
Methamphetamine
Psychotic Disorders
Schizophrenia
Hallucinations
Behavioral Symptoms

Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats

Hay, G. L., Baracz, S. J., Everett, N. A., Roberts, J., Costa, P. A., Arnold, J. C., McGregor, I. S. & Cornish, J. L., Dec 2018, In : Journal of psychopharmacology (Oxford, England). 32, 12, p. 1369-1378 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Cannabidiol
Methamphetamine
Motivation
Recurrence
Reinforcement Schedule

Randomised pilot study of cannabis cue exposure: reducing cue reactivity while building tolerance

Norberg, M. M., Barnier, E., Weidemann, G., Chakerian, K., Cornish, J. L. & Rapee, R. M., Jul 2018, In : Clinical Psychologist. 22, 2, p. 126-136 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Cannabis
Cues
Aptitude
Randomized Controlled Trials
Implosive Therapy
Oxytocin
Psychological Stress
Substance-Related Disorders
Drug Therapy
Social Behavior

The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement

Everett, N. A., McGregor, I. S., Baracz, S. J. & Cornish, J. L., 1 May 2018, In : Neuropharmacology. 133, p. 1-11 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Vasopressin Receptors
Methamphetamine
Oxytocin
Nucleus Accumbens
Oxytocin Receptors